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Biotechnology plays an important role as a lea-
ding-edge and cross-disciplinary technology for
innovation and growth.A country likeGermany,
poorly endowed in natural resources yet with a
highly-qualified workforce, must invest in this
innovative future technology in order to ensure
its long-term competitiveness. It is already hard
to imagine a world without biotechnology and
gene technology. They form the basis for medi-
cal andpharmaceutical products and for agricul-
tural and environmental technology. They offer
vast potential for optimising existing processes
as well as for the development of new products
and services.
In addition, biotechnology and gene technology
are among themost important fields for invest-
ment in the 21st century. The German Miners’,
Chemical andEnergyWorkers’Union, IGBCE,does
not emphasize this fact from an uncritical belief
in progress, but from a familiarity with those
whodo research andwork in these future-orient-
ed fields.
IGBCE says“yes”to biotechnology andgene tech-
nology. We are committed to this sector and do
not only strive to secure existing jobs, but seek
the creation of others in Germany.
By stating our position so clearly,we do not only
meet with approval. A common question posed
refers to the actual job-creation potential of the
biotechnology sector; for it is often assumed that
this technology will not make a considerable
impact on the development of the job market.
As no comprehensive studies had been carried
out in this field, IG BCE, together with the Ger-
manAssociationof Biotechnology Industries,DIB,
and financially aided by the foundation Hans-
Böckler-Stiftung, commissioned a study in order
to fill the research gap.
Two renowned research institutions, the Fraun-
hofer Institute for Systemsand Innovation (Fraun-
hofer ISI) and theGerman Institute for Economic
Research (DIW) started their research study entit-
led “Biotechnology in Germany – Employment
Potential and Competitiveness”.
Theprincipal aimwas to gain reliable figures and
assessments on the current economic and poli-
tical importance of biotechnology in Germany.
For the first time,not onlywere thedirect employ-
ment effects covered, but also the upstream and
downstreameconomic sectors included.This com-
prised research institutions, small andmedium-
size enterprises, the chemical and pharmaceuti-
cal industries as well as foodstuffs.
Not onlywas thequestionof the current and futu-
re economic importance of the individual bio-
technology areas in Germany placed at the fore-
front of the study, but also the role and function
of biotechnologies for the entire value-added
chain aswell as possible future scenarios for the
creation of value. Furthermore, production and
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sector structures in the biotechnology areaswere
listed and analysed – also taking its intercon-
nectednesswith traditional sectors into account
- in order to assess international competitiveness.
With the aim of devising a concrete and recom-
mended course of action, the critical constraints
and the key success factors in research, develop-
ment, productionand thedistributionof products
and processes in biotechnology were identified.
Additionally, the question to what degree bio-
technology is accepted or rejected by German
society, and to what extent this affects its chan-
ces for economic success was also incorporated
into the study.
Design of the study
In order to analyse the employment potential of
biotechnology,an investigativemodel consisting
of three variables (“pillars”) was utilised which
takes thedifferent employment impacts into con-
sideration. The calculation of the employment
effects was carried out by means of the input-
output model ISIS, developed at the Fraunhofer
ISI. It is based on the up-to-date input-output
tables of the Federal Statistical Office for the year
2002. They divided the German economy into 71
production and service sectors and six end-user
sectors (amongothers,private consumerdemand
and export). For certain elements, (the formati-
on of “biotechnology micro-segments”, the up-
datingof productivity indices) anadjustmentwas
made for the years 2004 and 2020, using appro-
priate statistical sources.
Bymeans of an elaborate“top-down/bottom-up”
procedure, employment scenarios were develo-
ped. A variety of methods was applied, among
others,written surveys, expert interviews aswell
as patent analysis and techno-economic studies.
Employment potentials
With the studyof relativelynewtechnology fields,
the actual market penetration contains a num-
ber of uncertainties. Employment effects are the-
refore givenwith lower and upper limits,which
can be considered as pessimistic and optimistic
market share estimates, respectively. The lower
and upper limits for the year 2020 can be inter-
preted as resulting from slow or rapid market
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penetration.
Generally, an increase in employment can be
expected in all three sub-segments: provision,
application and input. For the provision of bio-
technology know-howbyuniversities,R&D insti-
tutions, biotech outfitters, small and medium-
sized enterprises as well as plant breeders, an
employment potential of 89,000 to 93,000direct
employees was shown. About 97,000 to 113,000
direct employees can be expected for the year
2020, thus an increase of 10 – 20%.
In the field of application,a considerably greater
employment potential has been identified. The
biotech application industries comprise pharma-
ceuticals, chemicals and foodstuffs industries as
well as agriculture and environmental biotech-
nology. These industries apply biotechnological
methods, processes and products. The sum of
direct employment effects in these industries
amounts to 169,000 to 350,000 jobs in 2004. In
2020, this figure may rise to 272,000 to 483,000
employees.
Biotechnology application industries have a con-
siderable impact on employment in the supplier
industries, suchas, for example,mechanical engi-
neeringandplant construction. In 2004and2020,
these indirect employment effects were greater
thandirect employment impacts. The data range
shows employment figures of 217,000 to 471,000
in 2004 and even 369,000 to 682,000 in 2020.
Besides positive gross employment effects, we
also have to consider negative employment
impacts. They arise, for example, due to the sub-
stitution of traditional processes and products
(e.g. chemical-based pharmaceuticals, fossile-
based energy sources) and the expenditures and
investments thereby forgone. In addition, com-
pensatory and budget effects arise, as e.g., extra
costs (among others for research funding, subsi-
dies and tax exemptions for biofuels) must be
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compensated in the entire economyby reducing
expenditures in other places. These negative
effectswerenot calculatedwithin the framework
of this study. A calculation of such effects would
be very time and cost intensive.
An evaluation of Germany as a locati-
on for biotechnology – SWOT analysis
Aswell as site conditions, the international com-
petitiveness of the stakeholders in the sub-seg-
mentsofbiotechnology represents another impor-
tant factor for the realization of employment
potentials. Therefore, strengths and opportuni-
ties, as well as weaknesses and threats for Ger-
many as a location for biotechnology were exa-
mined by the study.
We can summarize the findings as follows:
Strengths and opportunities are mainly:
The availability of highly-qualified personnel
(among others scientists, engineers, technici-
ans)
A broad knowledge-base in all biotechnology
areas – primary and applied research
A large stock of technological assets (many
patents)
Dynamic, high-quality and highly regarded
scientific publications
A good research infrastructure with a diffe-
rentiated research landscape
A broad and competitive industrial basis – in
both application as well as supply industries
Large domestic markets and a well-establis-
hed access to major export markets
A good infrastructure (among others energy,
transport/logistics, IT)
Germany’s central geographical locationwit-
hin the EU
Public acceptance of biotechnology in the field
of health andmedicine aswell as in industri-
al production
Weaknesses and threats are among others:
Anunwillingness of industry stakeholders to
take risks and to invest compared to interna-
tional competitors
A paucity of venture capital in gestation
periods despite existing private capital
Relatively low R&D expenditures in German
biotech enterprises compared to internatio-
nal competitors
A lack in labourmobility between science and
industry – especially from industry to science
Future bottlenecks for (highly) qualified per-
sonnel (among others scientists, engineers,
technicians)
Increasing competition in theproduction area
mainly, especially from Asia
A highly complex structure of national and
international laws lacking in complementa-
rity, related elevated bureaucratic costs and
frequent poor service orientation of public
authorities
Low levels of public acceptance for biotech-
nological products in agriculture and food
Strong overseas orientation of leading enter-
prises in the area of green biotechnology
Conclusions
Today, a high-performance society is based on a
highly complex and interdependent economy.
Wehave to embrace this complexity to be able to
assess, for example, the likely impact of job los-
ses in one sector of theGermaneconomyonother
industries and sectors.
The results of the study show that several hun-
dred thousand people are already employed in
biotechnology and gene technology. Furthermo-
re, the study confirms that this sector possesses
enormouspowers of innovation capable of gene-
rating enormous employment potential, in par-
ticular in the applied (manufacturing and pro-
duction) industries. For example, by 2020, more
peoplewill work in biotechnology-related fields
than are currently employed in the entire chemi-
cal industry.
Itwas found that biotechnologyhas to beunders-
tood and appreciated as a cross-sectional tech-
nology. The progressmade in biotechnology and
gene technologyplays an important role inmany
core industries. Biotechnology has implications
via the chemical and pharmaceutical industries
for the environment, agriculture and food pro-
duction. Despitemarket penetration developing
at different pace in individual industries, pene-
tration is set to increase.
The SWOTanalysis illustrates the areas for action
that need to be addressed by politicians, entre-
preneurs and scientists.Nothing less than a con-
certed effort by all stakeholders is required if the
full potential of biotechnology for innovation,
growth and employment is to be realised.
In order to sustain and strengthen the perfor-
mance of the German economy amidst interna-
tional competition, we need to accelerate the
application of the full spectrum of biotechnolo-
gy. The upsurge in innovation triggered by this
cross-sectional technology creates newproducts
andmarkets,but not only that. Innovation in bio-
technology and gene technology safeguards, at
the same time, the future of research-intensive
and export-oriented industries. They form the
basis for the cutting-edge role of chemical and
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pharmaceutical production.
The result: biotechnology sustains and creates
hundreds of thousands of jobs,many ofwhich in
the future-proof research and service sectors.Bio-
technology andgene technology are indispensa-
ble ifwewant to remain competitive at an inter-
national level.
If Germany as an industrial location wants to
benefit from this opportunity, research and pro-
ductionneed to be bothwelcomed andnurtured
and - needless to say - German safety and envi-
ronmental standards must be applied.
Biotechnology and gene technology are difficult
issues. The complex interconnections are not
always easy to understand and objections domi-
nate the publicmood.Weneed to dealwith these
ethical issues and the fears they engender in the
population at large. Enterprises need to commu-
nicate openly about their work and especially
about their products. We need an open and fair
dialogue about the opportunities and risks.Only
if we succeed in convincing people of the bene-
fits of these products, we will manage to create
acceptance for biotechnology inGermany in the
long term.
As a country poor in natural resources, we need
to focus on know-howand technology inGerma-
ny. Innovation can act as a driving force for our
economy.Wecan thus ensureprosperity and crea-
te urgently-needed employment. The trend
towards losing jobs, especially in traditional pro-
duction sectors will probably continue over the
comingyears. In order to remain competitive,we
need innovation,newproducts andnewmarkets.
The growth in the industry of biotechnology is
therefore likely to play an even greater role here.
The results of the study presented thus serve to
both encourage and confirm the views held by
IGBCE.Wehave always emphasized that biotech-
nology andgene technology offer great opportu-
nities forGermanknow-howand technology,and
that investment in this technology isworthwhi-
le. We will continue to commit our resources to
this end.
This study was commissioned by Hans-Böckler-
Stiftung, theGermanMiners’,Chemical andEner-
gy Workers’ Union and the German Association
of Biothechnology Industries.
References
Nusser,M., Soete,B.,Wydra,S. (2007),Wettbewerbsfähigkeit
und Beschäftigungspotentiale der Biotechnologie in
Deutschland.EditionderHansBöckler-Stiftung 197,Düs-
seldorf.
Journal of Business Chemistry 2008, 5 (2) © 2008 Institute of Business Administration
A Motor for Future-Proof Jobs
68
